Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Non-Small-Cell Lung × Diet × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 4 Malnutrition 2 Lymphoma, Follicular 2 Lymphoma 2 Weight Loss 1 Waldenstrom Macroglobulinemia 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1 Obesity 1 Neoplasms 1 Myelodysplastic Syndromes 1 Multiple Endocrine Neoplasia Type 1 1 Medical Oncology 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Infections 1 Fasting 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Colorectal Cancer Prevention 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Neoplasms 1 Breast Carcinoma In Situ 1

Interventions

pembrolizumab 226 Carboplatin 199 Pemetrexed 167 Cisplatin 118 Paclitaxel 107 Nivolumab 88 durvalumab 75 osimertinib 71 Docetaxel 69 Specimen Handling 54 atezolizumab 49 Magnetic Resonance Spectroscopy 48 Drug Therapy 47 Gemcitabine 44 Radiotherapy 41 Bevacizumab 36 Radiosurgery 35 cemiplimab 33 Ipilimumab 33 130-nm albumin-bound paclitaxel 32 tislelizumab 31 Cetuximab 23 Taxes 20 Immunotherapy 20 Immune Checkpoint Inhibitors 20 amivantamab 18 Platinum Compounds 18 Blood Specimen Collection 17 Biopsy 17 Surgical Procedures, Operative 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06671613 2025-11-10

Stage IV NSCLC

VA Office of Research and Development

Phase NA Recruiting

Carcinoma, Non-Small-Cell Lung, Fasting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡